Outcome of Surgical Resection after Neoadjuvant Peptide Receptor Radionuclide Therapy (PRRT) for Pancreatic Neuroendocrine Neoplasms: A Case-Matched Analysis

#1863

Introduction: Neoadjuvant Peptide receptor radionuclide therapy (NPRRT) can be an option for advanced pancreatic neuroendocrine neoplasms (PNEN) before surgery. Is not clear if NPRRT increases postoperative morbidity

Aim(s): To evaluate effects of NPRRT in patients with PNEN

Materials and methods: Pts with metastatic and/or locally advanced PNEN who underwent NPRRT were compared with pts who underwent upfront surgery (control group). Pts were matched for tumor size, grading, staging and intent of resection

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Muffatti F, Partelli S, Andreasi V, Bertani E, Bartolomei M,

Keywords: neoadjuvant PRRT, PNEN, surgery,